NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 38 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,454 | -43.1% | 97,900 | +5.9% | 0.00% | – |
| Q2 2023 | $44,698 | -31.9% | 92,447 | -7.2% | 0.00% | – |
| Q1 2023 | $65,678 | -68.2% | 99,647 | -46.5% | 0.00% | – |
| Q4 2022 | $206,744 | +26.8% | 186,256 | -15.5% | 0.00% | – |
| Q3 2022 | $163,000 | -21.6% | 220,500 | -36.4% | 0.00% | – |
| Q2 2022 | $208,000 | -76.8% | 346,466 | -5.3% | 0.00% | – |
| Q1 2022 | $896,000 | -61.3% | 365,800 | -24.5% | 0.00% | – |
| Q4 2021 | $2,317,000 | -54.1% | 484,700 | -11.0% | 0.00% | -100.0% |
| Q3 2021 | $5,051,000 | – | 544,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
| Virtu Financial LLC | 46,210 | $30 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
| UBS Group AG | 18,611 | $12,265 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
| OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |